Keyphrases
A1 Receptor
38%
All-cause Mortality
15%
Body Mass Index
14%
Coefficient of Variance
21%
Confidence Interval
21%
Denosumab
51%
Differentiated Thyroid Cancer
33%
Disease-specific Mortality
14%
Extrathyroidal Extension
15%
General Surgery
15%
Glucagon-like
38%
Glucose Variability
21%
Glycemic Control
20%
Hormone Levels
17%
Hospitalization
34%
Hospitalized Patients
45%
Hypocalcemia
25%
Hypoglycemia
17%
Hypothyroidism
25%
In-hospital Mortality
16%
Ischemic Stroke
14%
Keratinocytes
25%
Kidney Transplant Recipients
25%
Length of Stay
15%
Lobectomy
25%
Long-term Mortality
29%
Meta-analysis
28%
Mortality Risk
48%
Nodule
15%
Osteoporosis
28%
Oxidative Stress
17%
Patients with Diabetes
31%
Patients with Diabetes Mellitus
27%
Pre-admission
19%
Primary Hyperparathyroidism (pHPT)
25%
Radioiodine
14%
Radioiodine Therapy
14%
Radioiodine Treatment
14%
Receptor Agonist
38%
Risk Ratio
17%
Serum Calcium
18%
SIADH
16%
Surgery Department
15%
Surgical Ward
14%
Systematic Meta-analysis
38%
Thyroid Cancer
17%
Thyroid Hormones
25%
Type 1 Diabetes Mellitus (T1DM)
100%
Vitamin D
25%
Without Diabetes
38%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
16%
All Cause Mortality
15%
Bone Marrow Suppression
12%
Brain Ischemia
14%
Caspase
17%
Cerebrovascular Accident
9%
Denosumab
51%
Diabetes Mellitus
76%
Differentiated Thyroid Cancer
16%
Diseases
31%
Dopamine Receptor Stimulating Agent
12%
Drug-Drug Interaction
12%
Endocrine Disease
12%
Epidermal Growth Factor Receptor
12%
Glucagon Like Peptide 1 Receptor Agonist
38%
Graves Disease
12%
Hospital Mortality
12%
Hypernatremia
10%
Hyperprolactinemia
12%
Hypocalcaemia
25%
Hypoglycemia
14%
Hyponatremia
25%
Hypothyroidism
34%
Inappropriate Vasopressin Secretion
15%
Infection
12%
Levothyroxine
6%
Lung Cancer
12%
Phosphotransferase
12%
Primary Hyperparathyroidism
12%
Programmed Cell Death
12%
Radioactive Iodine
19%
Randomized Controlled Trial
21%
Recurrent Disease
16%
Remission
12%
Retrospective Study
9%
Sodium Glucose Cotransporter 2 Inhibitor
12%
Thiazide Diuretic Agent
12%
Thyrotropin
25%
Tumor Necrosis Factor
21%
Vitamin D
26%
Medicine and Dentistry
Adverse Event
8%
All Cause Mortality
6%
Bone Marrow Suppression
12%
Conservative Treatment
12%
Contralateral
14%
Diabetes
13%
Diabetes Mellitus
38%
Differentiated Thyroid Cancer
29%
Disease Severity
12%
Diseases
43%
Elderly Patient
12%
Endocrine Disease
12%
General Surgery
12%
Glucagon-Like Peptide-1 Agonist
12%
Glycemic
12%
Graves' Disease
12%
Hormone Determination
12%
Hospital Mortality
8%
Hyperglycemia
12%
Hypernatremia
10%
Hyperparathyroidism
12%
Hyponatremia
25%
Hypothyroidism
21%
Infection
7%
Infectious Disease
12%
Isotopes of Calcium
6%
Kidney Graft
12%
Leukocyte
5%
Lipodystrophy
12%
Lobectomy
25%
Lung Cancer
12%
Meta-Analysis
12%
Metreleptin
12%
Odds Ratio
9%
Papillary Thyroid Cancer
13%
Parathyroidectomy
6%
Patient with Diabetes
7%
Primary Hyperparathyroidism
12%
Radioactive Iodine
19%
Radioiodine Therapy
16%
Recurrent Disease
28%
Retrospective Study
6%
Spontaneous Remission
12%
Systematic Review
12%
Thyroglobulin
14%
Thyroglobulin Antibody
12%
Thyroid Cancer
14%
Thyroidectomy
12%
Thyrotropin
12%
Urinary System
6%